Click here to link to original post
Health Canada has initiated a safety review on Xeljanz and Xeljanz XR (tofacitinib), used to treat arthritis and ulcerative colitis
Health Canada is informing Canadians and health care professionals that it is conducting a safety review of Xeljanz and Xeljanz XR (tofacitinib) after a clinical trial identified an increased risk of serious heart-related issues and cancer in trial participants.
Health Canada is advising Canadians not to use face masks that contain graphene because there is a potential that they could inhale graphene particles, which may pose health risks.
Unauthorized health products seized from Tokyo Beauty & Health Care in Richmond, B.C., may pose serious health risks
Health Canada has seized several health products—including eye drops, an eyewash and an acne gel—from Tokyo Beauty & Health Care in Richmond, British Columbia (#120, 8191 Westminster Highway), because they are unauthorized and may pose serious health risks.
Certain lots of hand sanitizers are being recalled from the market because they do not meet Health Canada requirements. Reasons for recall include: